124 related articles for article (PubMed ID: 30522558)
21. Metformin targets gastric cancer stem cells.
Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
[TBL] [Abstract][Full Text] [Related]
22. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma.
Soares AS; Costa VM; Diniz C; Fresco P
Biomed Pharmacother; 2013 Oct; 67(8):777-89. PubMed ID: 24035253
[TBL] [Abstract][Full Text] [Related]
24. Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.
Calvani M; Bianchini F; Taddei ML; Becatti M; Giannoni E; Chiarugi P; Calorini L
Oncotarget; 2016 Aug; 7(32):51138-51149. PubMed ID: 27303923
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
Kumar D; Gorain M; Kundu G; Kundu GC
Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
[TBL] [Abstract][Full Text] [Related]
26. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
27. Differentiation-inducing and anti-proliferative activities of isoliquiritigenin and all-trans-retinoic acid on B16F0 melanoma cells: Mechanisms profiling by RNA-seq.
Chen X; Yang M; Hao W; Han J; Ma J; Wang C; Sun S; Zheng Q
Gene; 2016 Oct; 592(1):86-98. PubMed ID: 27461947
[TBL] [Abstract][Full Text] [Related]
28. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
29. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo.
Jia D; Tan Y; Liu H; Ooi S; Li L; Wright K; Bennett S; Addison CL; Wang L
Oncotarget; 2016 Jan; 7(1):771-85. PubMed ID: 26506421
[TBL] [Abstract][Full Text] [Related]
30. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
31. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
33. All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells.
Li RJ; Ying X; Zhang Y; Ju RJ; Wang XX; Yao HJ; Men Y; Tian W; Yu Y; Zhang L; Huang RJ; Lu WL
J Control Release; 2011 Feb; 149(3):281-91. PubMed ID: 20971141
[TBL] [Abstract][Full Text] [Related]
34. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
35. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
[TBL] [Abstract][Full Text] [Related]
36. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
37. Impact of carboplatin plus paclitaxel combined with endostar against A375 melanoma cells: An in vitro and in vivo analysis.
Zheng AW; Jia DD; Xia LM; Jin G; Wu H; Li T
Biomed Pharmacother; 2016 Oct; 83():1321-1326. PubMed ID: 27571875
[TBL] [Abstract][Full Text] [Related]
38. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells.
Shen S; Xu X; Lin S; Zhang Y; Liu H; Zhang C; Mo R
Nat Nanotechnol; 2021 Jan; 16(1):104-113. PubMed ID: 33437035
[TBL] [Abstract][Full Text] [Related]
39. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
40. The combination of the antiestrogen endoxifen with all-trans-retinoic acid has anti-proliferative and anti-migration effects on melanoma cells without inducing significant toxicity in non-neoplasic cells.
Ribeiro MP; Silva FS; Paixão J; Santos AE; Custódio JB
Eur J Pharmacol; 2013 Sep; 715(1-3):354-62. PubMed ID: 23712006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
